{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:30:59Z","timestamp":1784691059513,"version":"3.55.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00705-026-06639-9","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:08:23Z","timestamp":1778148503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular insights into the mechanisms of occult hepatitis B virus infection"],"prefix":"10.1007","volume":"171","author":[{"given":"Sina","family":"Mahdavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Abyazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi Esmaeili","family":"Gouvarchin Ghaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Golmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3197-9509","authenticated-orcid":false,"given":"Ali","family":"Salimi Jeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"17","key":"6639_CR1","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.12998\/wjcc.v10.i17.5518","volume":"10","author":"GS Gherlan","year":"2022","unstructured":"Gherlan GS (2022) Occult hepatitis B - the result of the host immune response interaction with different genomic expressions of the virus. World J Clin Cases 10(17):5518\u20135530. https:\/\/doi.org\/10.12998\/wjcc.v10.i17.5518","journal-title":"World J Clin Cases"},{"issue":"12","key":"6639_CR2","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3748\/wjg.v17.i12.1549","volume":"17","author":"M Romero","year":"2011","unstructured":"Romero M, Madej\u00f3n A, Fern\u00e1ndez-Rodr\u00edguez C, Garc\u00eda-Samaniego J (2011) Clinical significance of occult hepatitis B virus infection. World J Gastroenterol 17(12):1549\u20131552. https:\/\/doi.org\/10.3748\/wjg.v17.i12.1549","journal-title":"World J Gastroenterol"},{"key":"6639_CR3","doi-asserted-by":"publisher","first-page":"1186877","DOI":"10.3389\/fcimb.2023.1186877","volume":"13","author":"C Wang","year":"2023","unstructured":"Wang C, Xue R, Wang X, Xiao L, Xian J (2023) High-sensitivity HBV DNA test for the diagnosis of occult HBV infection: commonly used but not reliable. Front Cell Infect Microbiol 13:1186877. https:\/\/doi.org\/10.3389\/fcimb.2023.1186877","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"6639_CR4","doi-asserted-by":"publisher","first-page":"596","DOI":"10.5604\/01.3001.0012.0927","volume":"17","author":"J Muto","year":"2018","unstructured":"Muto J, Sugiyama M, Shirabe K, Mukaide M, Kirikae-Muto I, Ikegami T, Yoshizumi T, Yamashita YI, Maehara Y, Mizokami M (2018) Frequency and characteristics of occult hepatitis B infection among hepatocellular carcinoma patients in Japan. Ann Hepatol 17(4):596\u2013603. https:\/\/doi.org\/10.5604\/01.3001.0012.0927","journal-title":"Ann Hepatol"},{"issue":"2","key":"6639_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","volume":"71","author":"G Raimondo","year":"2019","unstructured":"Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS, Allain J-P, Berg T, Bertoletti A, Brunetto MR (2019) Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol 71(2):397\u2013408. https:\/\/doi.org\/10.1016\/j.jhep.2019.03.034","journal-title":"J Hepatol"},{"issue":"10","key":"6639_CR6","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s11010-023-04660-z","volume":"478","author":"P He","year":"2023","unstructured":"He P, Zhang P, Fang Y, Han N, Yang W, Xia Z, Zhu Y, Zhang Z, Shen J (2023) The role of HBV cccDNA in occult hepatitis B virus infection. Mol Cell Biochem 478(10):2297\u20132307. https:\/\/doi.org\/10.1007\/s11010-023-04660-z","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"6639_CR7","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","volume":"49","author":"G Raimondo","year":"2008","unstructured":"Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Crax\u00ec A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Tr\u00e9po C, Villa E, Will H, Zanetti AR, Zoulim F (2008) Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 49(4):652\u2013657. https:\/\/doi.org\/10.1016\/j.jhep.2008.07.014","journal-title":"J Hepatol"},{"issue":"1","key":"6639_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/epirev\/mxj009","volume":"28","author":"CW Shepard","year":"2006","unstructured":"Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28(1):112\u2013125. https:\/\/doi.org\/10.1093\/epirev\/mxj009","journal-title":"Epidemiol Rev"},{"key":"6639_CR9","doi-asserted-by":"publisher","unstructured":"Deng L, Li X, Shi Z, Jiang P, Chen D, Ma L (2012) Maternal and perinatal outcome in cases of fulminant viral hepatitis in late pregnancy. Int J Gynaecol Obstet. ;119(2):145-8. https:\/\/doi.org\/10.1016\/j.ijgo.2012.05.041. Epub 2012 Sep 1. PMID: 22947378","DOI":"10.1016\/j.ijgo.2012.05.041"},{"issue":"10","key":"6639_CR10","first-page":"1452","volume":"26","author":"YZ Yin","year":"2006","unstructured":"Yin YZ, Chen XW, Li XM, Hou HY, Shi ZJ (2006) [Intrauterine HBV infection: risk factors and impact of HBV DNA]. Nan Fang Yi Ke Da Xue Xue Bao 26(10):1452\u20131454 Chinese. PMID: 17062350","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"5 Suppl","key":"6639_CR11","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1002\/hep.22898","volume":"49","author":"BJ McMahon","year":"2009","unstructured":"McMahon BJ (2009) The natural history of chronic hepatitis B virus infection. Hepatology 49(5 Suppl):S45\u201355. https:\/\/doi.org\/10.1002\/hep.22898","journal-title":"Hepatology"},{"issue":"2","key":"6639_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1128\/cmr.12.2.351","volume":"12","author":"FJ Mahoney","year":"1999","unstructured":"Mahoney FJ (1999) Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 12(2):351\u2013366. https:\/\/doi.org\/10.1128\/cmr.12.2.351","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"6639_CR13","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/nm1096-1104","volume":"2","author":"B Rehermann","year":"1996","unstructured":"Rehermann B, Ferrari C, Pasquinelli C, Chisari FV (1996) The hepatitis B virus persists for decades after patients\u2019 recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 2(10):1104\u20131108. https:\/\/doi.org\/10.1038\/nm1096-1104","journal-title":"Nat Med"},{"issue":"4","key":"6639_CR14","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jhep.2017.05.008","volume":"67","author":"AS Lok","year":"2017","unstructured":"Lok AS, Zoulim F, Dusheiko G, Ghany MG (2017) Hepatitis B cure: From discovery to regulatory approval. J Hepatol 67(4):847\u2013861. https:\/\/doi.org\/10.1016\/j.jhep.2017.05.008","journal-title":"J Hepatol"},{"issue":"8","key":"6639_CR15","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1136\/gutjnl-2013-305517","volume":"63","author":"GA Kim","year":"2014","unstructured":"Kim GA, Lim YS, An J, Lee D, Shim JH, Kim KM, Lee HC, Chung YH, Lee YS, Suh DJ (2014) HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability. Gut 63(8):1325\u20131332. https:\/\/doi.org\/10.1136\/gutjnl-2013-305517","journal-title":"Gut"},{"issue":"10","key":"6639_CR16","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1111\/liv.12807","volume":"35","author":"T Pollicino","year":"2015","unstructured":"Pollicino T, Raimondo G, Navarra G, Sangiovanni A, Raffa G, Ciancio A, Smedile A, Bertuccio A, Barbera A, Tripodi G, Saitta C (2015) Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. Liver Int 35(10):2311\u20132317. https:\/\/doi.org\/10.1111\/liv.12807","journal-title":"Liver Int"},{"key":"6639_CR17","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1053\/j.gastro.2010.01.042","volume":"138","author":"JD Chen","year":"2010","unstructured":"Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, Wang LY, Su J, Sun CA, Liaw YF, Chen CJ (2010) Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology 138:1747\u20131754. https:\/\/doi.org\/10.1053\/j.gastro.2010.01.042","journal-title":"Gastroenterology"},{"key":"6639_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jhep.2009.05.022","volume":"51","author":"M Levrero","year":"2009","unstructured":"Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M (2009) Control of cccDNA function in hepatitis B virus infection. J Hepatol 51:581\u2013592. https:\/\/doi.org\/10.1016\/j.jhep.2009.05.022","journal-title":"J Hepatol"},{"key":"6639_CR19","doi-asserted-by":"publisher","unstructured":"Chapus F, Martinez MG, Testoni B, Zoulim F (2021) Molecular Virology and Life Cycle of Hepatitis B Virus. In: Hepatitis B (ed) Virus and Liver Disease. Springer, pp 1\u201327. https:\/\/doi.org\/10.1007\/978-981-16-3615-8_1","DOI":"10.1007\/978-981-16-3615-8_1"},{"issue":"4","key":"6639_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3390\/v16040609","volume":"16","author":"A G\u00f3mez-Moreno","year":"2024","unstructured":"G\u00f3mez-Moreno A, Ploss A (2024) Mechanisms of hepatitis B virus cccDNA and minichromosome formation and HBV gene transcription. Viruses 16(4):609. https:\/\/doi.org\/10.3390\/v16040609","journal-title":"Viruses"},{"issue":"5","key":"6639_CR21","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3390\/v13050757","volume":"13","author":"J Diogo Dias","year":"2021","unstructured":"Diogo Dias J, Sarica N, Neuveut C (2021) Early steps of hepatitis B life cycle: from capsid nuclear import to cccDNA formation. Viruses 13(5):757. https:\/\/doi.org\/10.3390\/v13050757","journal-title":"Viruses"},{"issue":"5","key":"6639_CR22","doi-asserted-by":"publisher","first-page":"866","DOI":"10.4254\/wjh.v14.i5.866","volume":"14","author":"C Bianca","year":"2022","unstructured":"Bianca C, Sidhartha E, Tiribelli C, El-Khobar KE, Sukowati CHC (2022) Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA. World J Hepatol 14(5):866\u2013884. https:\/\/doi.org\/10.4254\/wjh.v14.i5.866","journal-title":"World J Hepatol"},{"issue":"4","key":"6639_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1515\/almed-2022-0065","volume":"3","author":"M Lalana Garc\u00e9s","year":"2022","unstructured":"Lalana Garc\u00e9s M, Ortiz Pastor O, Sol\u00e9 Enrech G, Guerra-Ruiz AR, Casals Mercadal G, Almer\u00eda Lafuente A, Ballesteros Vizoso MA, Medina PG, Salg\u00fcero Fern\u00e1ndez S, Zamora Trillo A (2022) Control of occult hepatitis B virus infection. Adv Lab Med 3(4):321\u2013330. https:\/\/doi.org\/10.1515\/almed-2022-0065","journal-title":"Adv Lab Med"},{"issue":"7","key":"6639_CR24","doi-asserted-by":"publisher","first-page":"e07586","DOI":"10.1016\/j.heliyon.2021.e07586","volume":"7","author":"Y Miyakawa","year":"2021","unstructured":"Miyakawa Y, Otsuka M, Sekiba K, Funato K, Koike K (2021) Humanized virus-suppressing factor inhibits hepatitis B virus infection by targeting viral cell entry. Heliyon 7(7):e07586. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07586","journal-title":"Heliyon"},{"key":"6639_CR25","doi-asserted-by":"publisher","unstructured":"Bai F, Yano Y, Fukumoto T, Takebe A, Tanaka M, Kuramitsu K, Anggorowati N, Rinonce HT, Widasari DI, Saito M (2013) Quantification of pregenomic RNA and covalently closed circular DNA in hepatitis B virus-related hepatocellular carcinoma. Int J Hepatol. 2013:849290. https:\/\/doi.org\/10.1155\/2013\/849290","DOI":"10.1155\/2013\/849290"},{"issue":"19","key":"6639_CR26","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.12998\/wjcc.v9.i19.4890","volume":"9","author":"GO Elpek","year":"2021","unstructured":"Elpek GO (2021) Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update. World J Clin Cases 9(19):4890\u20134917. https:\/\/doi.org\/10.12998\/wjcc.v9.i19.4890","journal-title":"World J Clin Cases"},{"issue":"4","key":"6639_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.36233\/0507-4088-291","volume":"70","author":"AA Kushch","year":"2025","unstructured":"Kushch AA (2025) Occult hepatitis B: prevalence and clinical significance. Role in liver pathology and in viral coinfections. Vopr Virusol 70(4):299\u2013316. https:\/\/doi.org\/10.36233\/0507-4088-291","journal-title":"Vopr Virusol"},{"issue":"1","key":"6639_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00281-012-0327-7","volume":"35","author":"G Raimondo","year":"2013","unstructured":"Raimondo G, Caccamo G, Filomia R, Pollicino T (2013) Occult HBV infection. Semin Immunopathol 35(1):39\u201352. https:\/\/doi.org\/10.1007\/s00281-012-0327-7","journal-title":"Semin Immunopathol"},{"issue":"11","key":"6639_CR29","doi-asserted-by":"publisher","first-page":"e0150925","DOI":"10.1128\/jvi.01509-25","volume":"99","author":"X Yu","year":"2025","unstructured":"Yu X, Liu CD, Shen S, Kim ES, Liu Z, Zhang H, Sun N, Liu Y, Martensen PM, Huang Y, Guo H (2025) Interferon alpha-inducible protein 27 (IFI27) inhibits hepatitis B virus (HBV) transcription through downregulating cellular transcription factor C\/EBP\u03b1. J Virol 99(11):e0150925. https:\/\/doi.org\/10.1128\/jvi.01509-25","journal-title":"J Virol"},{"issue":"11","key":"6639_CR30","doi-asserted-by":"publisher","first-page":"e0129525","DOI":"10.1128\/jvi.01295-25","volume":"99","author":"BH Zhang","year":"2025","unstructured":"Zhang BH, Zhou Y, Horrigan S, Zoulim F, Hu J, Zhang YY (2025) Replication-driven HBV cccDNA loss in chimeric mice with humanized livers. J Virol 99(11):e0129525. https:\/\/doi.org\/10.1128\/jvi.01295-25","journal-title":"J Virol"},{"issue":"6","key":"6639_CR31","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1002\/hep.29479","volume":"66","author":"X Hong","year":"2017","unstructured":"Hong X, Kim ES, Guo H (2017) Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B. Hepatology 66(6):2066\u20132077. https:\/\/doi.org\/10.1002\/hep.29479","journal-title":"Hepatology"},{"issue":"1","key":"6639_CR32","doi-asserted-by":"publisher","first-page":"101215","DOI":"10.1016\/j.gendis.2024.101215","volume":"12","author":"J Ren","year":"2025","unstructured":"Ren J, Cheng S, Ren F, Gu H, Wu D, Yao X, Tan M, Huang A, Chen J (2025) Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA. Genes Dis 12(1):101215. https:\/\/doi.org\/10.1016\/j.gendis.2024.101215","journal-title":"Genes Dis"},{"issue":"9","key":"6639_CR33","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/procel\/pwaf021","volume":"16","author":"W Liu","year":"2025","unstructured":"Liu W, Zhang X, Deng Y, Wang D, Li H (2025) Unfolding HBx for an epigenetic switch of HBV cccDNA minichromosome. Protein Cell 16(9):753\u2013763. https:\/\/doi.org\/10.1093\/procel\/pwaf021","journal-title":"Protein Cell"},{"issue":"1","key":"6639_CR34","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1186\/s12967-025-07440-z","volume":"23","author":"X Hong","year":"2025","unstructured":"Hong X, Chen X, Zhang P, Gao Z, Tao C, Wang H, Zhang Z (2025) Dual defects in HBsAg antigenicity and secretion caused by the C138R mutation in the S gene trigger occult hepatitis B virus infection. J Transl Med 23(1):1379. https:\/\/doi.org\/10.1186\/s12967-025-07440-z","journal-title":"J Transl Med"},{"issue":"9","key":"6639_CR35","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3390\/pathogens12091146","volume":"12","author":"A Jose-Abrego","year":"2023","unstructured":"Jose-Abrego A, Roman S, Laguna-Meraz S, Panduro A (2023) Host and HBV interactions and their potential impact on clinical outcomes. Pathogens 12(9):1146. https:\/\/doi.org\/10.3390\/pathogens12091146","journal-title":"Pathogens"},{"key":"6639_CR36","doi-asserted-by":"publisher","first-page":"1018053","DOI":"10.3389\/fimmu.2022.1018053","volume":"13","author":"Z Yang","year":"2022","unstructured":"Yang Z, Sun B, Xiang J, Wu H, Kan S, Hao M, Chang L, Liu H, Wang D, Liu W (2022) Role of epigenetic modification in interferon treatment of hepatitis B virus infection. Front Immunol 13:1018053. https:\/\/doi.org\/10.3389\/fimmu.2022.1018053","journal-title":"Front Immunol"},{"issue":"10","key":"6639_CR37","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.3390\/v13102053","volume":"13","author":"MC Kuhns","year":"2021","unstructured":"Kuhns MC, Holzmayer V, Anderson M, McNamara AL, Sauleda S, Mbanya D, Duong PT, Dung NT, Cloherty GA (2021) Molecular and serological characterization of hepatitis B virus (HBV)-positive samples with very low or undetectable levels of HBV surface antigen. Viruses 13(10):2053. https:\/\/doi.org\/10.3390\/v13102053","journal-title":"Viruses"},{"issue":"1","key":"6639_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12985-024-02366-2","volume":"21","author":"H Liu","year":"2024","unstructured":"Liu H, Chen S, Liu X, Lou J (2024) Effect of S-region mutations on HBsAg in HBsAg-negative HBV-infected patients. Virol J 21(1):92. https:\/\/doi.org\/10.1186\/s12985-024-02366-2","journal-title":"Virol J"},{"issue":"5","key":"6639_CR39","doi-asserted-by":"publisher","first-page":"e0155654","DOI":"10.1371\/journal.pone.0155654","volume":"11","author":"J Chen","year":"2016","unstructured":"Chen J, Liu Y, Zhao J, Xu Z, Chen R, Si L, Lu S, Li X, Wang S, Zhang K (2016) Characterization of novel hepatitis B virus PreS\/S-gene mutations in a patient with occult hepatitis B virus infection. PLoS ONE 11(5):e0155654. https:\/\/doi.org\/10.1371\/journal.pone.0155654","journal-title":"PLoS ONE"},{"key":"6639_CR40","doi-asserted-by":"publisher","first-page":"1063616","DOI":"10.3389\/fmicb.2022.1063616","volume":"13","author":"Y Yan","year":"2022","unstructured":"Yan Y, Sun H, Chang L, Ji H, Jiang X, Song S, Xiao Y, Feng K, Nuermaimaiti A, Lu Z (2022) Circulating immune complexes and mutations of HBsAg are associated with the undetectable HBsAg in anti-HBs and HBeAg positive occult hepatitis B virus infection. Front Microbiol 13:1063616. https:\/\/doi.org\/10.3389\/fmicb.2022.1063616","journal-title":"Front Microbiol"},{"issue":"9","key":"6639_CR41","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/v11090778","volume":"11","author":"I Lazarevic","year":"2019","unstructured":"Lazarevic I, Banko A, Miljanovic D, Cupic M (2019) Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression. Viruses 11(9):778. https:\/\/doi.org\/10.3390\/v11090778","journal-title":"Viruses"},{"issue":"3","key":"6639_CR42","first-page":"329","volume":"138","author":"S Sengupta","year":"2013","unstructured":"Sengupta S, Panda SK, Acharya SK, Durgapal H (2013) Role of hepatitis B virus genotype D & its mutants in occult hepatitis B infection. Indian J Med Res 138(3):329\u2013339 PMID: 24135177","journal-title":"Indian J Med Res"},{"issue":"1","key":"6639_CR43","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1128\/CMR.00018-11","volume":"25","author":"J Samal","year":"2012","unstructured":"Samal J, Kandpal M, Vivekanandan P (2012) Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev 25(1):142\u2013163. https:\/\/doi.org\/10.1128\/CMR.00018-11","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"6639_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.15406\/jhvrv.2015.02.00046","volume":"2","author":"P Perazzo","year":"2015","unstructured":"Perazzo P, Eguibar N, Gonzalez RH, Nusblat AD, Cuestas ML (2015) Hepatitis B virus (HBV) and s-escape mutants: From the beginning until now. J Hum Virol Retrovirol 2(3):45\u201355. https:\/\/doi.org\/10.15406\/jhvrv.2015.02.00046","journal-title":"J Hum Virol Retrovirol"},{"issue":"1","key":"6639_CR45","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1038\/s41598-025-34788-5","volume":"16","author":"A Adugna","year":"2026","unstructured":"Adugna A, Abebaw D, Malik T, Jemal M (2026) Occult hepatitis B virus infection among hepatitis B surface antigen negative vaccinated healthcare workers in East Gojjam zone hospitals. Sci Rep 16(1):4701. https:\/\/doi.org\/10.1038\/s41598-025-34788-5","journal-title":"Sci Rep"},{"issue":"3","key":"6639_CR46","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1111\/jam.15351","volume":"132","author":"NAA de Almeida","year":"2022","unstructured":"de Almeida NAA, de Paula VS (2022) Occult Hepatitis B virus (HBV) infection and challenges for hepatitis elimination: A literature review. J Appl Microbiol 132(3):1616\u20131635. https:\/\/doi.org\/10.1111\/jam.15351","journal-title":"J Appl Microbiol"},{"issue":"3","key":"6639_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/vaccines5030024","volume":"5","author":"AM Ortega-Prieto","year":"2017","unstructured":"Ortega-Prieto AM, Dorner M (2017) Immune evasion strategies during chronic hepatitis B and C virus infection. Vaccines 5(3):24. https:\/\/doi.org\/10.3390\/vaccines5030024","journal-title":"Vaccines"},{"key":"6639_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2024.110184","author":"RAA Pond\u00e9","year":"2024","unstructured":"Pond\u00e9 RAA, Amorim GSP (2024) Exchanges in the \u2018a\u2019 determinant of the hepatitis B virus surface antigen revisited. Virology. https:\/\/doi.org\/10.1016\/j.virol.2024.110184. 599:110184","journal-title":"Virology"},{"key":"6639_CR49","doi-asserted-by":"publisher","first-page":"127130","DOI":"10.1016\/j.vaccine.2025.127130","volume":"56","author":"DP Wibowo","year":"2025","unstructured":"Wibowo DP, Chalid MT, Rasyak MR, El Khobar KE, Turyadi, Sjahril R, Wahyuni R, Setiady Y, Muljono DH (2025) Characteristics of hepatitis B virus surface protein and occult hepatitis B infection in infants with immunoprophylaxis failure from Indonesia. Vaccine 56:127130. https:\/\/doi.org\/10.1016\/j.vaccine.2025.127130","journal-title":"Vaccine"},{"key":"6639_CR50","doi-asserted-by":"publisher","first-page":"740464","DOI":"10.3389\/fmicb.2021.740464","volume":"12","author":"C Xu","year":"2021","unstructured":"Xu C, Chen J, Chen X (2021) Host innate immunity against hepatitis viruses and viral immune evasion. Front Microbiol 12:740464. https:\/\/doi.org\/10.3389\/fmicb.2021.740464","journal-title":"Front Microbiol"},{"key":"6639_CR51","doi-asserted-by":"publisher","first-page":"850665","DOI":"10.3389\/fmicb.2022.850665","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Luo S, Li T, Wang M, Huang J, Liao Q, Liu B, Rong X, Li L, Allain J-P, Fu Y, Li C (2022) Hepatitis B Virus-Specific Cellular Immunity Contributes to the Outcome of Occult Hepatitis B Virus Infection. Front Microbiol 13:850665. https:\/\/doi.org\/10.3389\/fmicb.2022.850665","journal-title":"Front Microbiol"},{"issue":"6","key":"6639_CR52","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.virs.2023.10.007","volume":"38","author":"L Wang","year":"2023","unstructured":"Wang L, Zeng X, Wang Z, Fang L, Liu J (2023) Recent advances in understanding T cell activation and exhaustion during HBV infection. Virol Sin 38(6):851\u2013859. https:\/\/doi.org\/10.1016\/j.virs.2023.10.007","journal-title":"Virol Sin"},{"issue":"8","key":"6639_CR53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.22192\/ijcrms.2017.03.08.014","volume":"3","author":"EI Obeagu","year":"2017","unstructured":"Obeagu EI, Obeagu GU (2017) Occult Hepatitis B infection and immunity. Int J Curr Res Med Sci 3(8):89\u2013100. https:\/\/doi.org\/10.22192\/ijcrms.2017.03.08.014","journal-title":"Int J Curr Res Med Sci"},{"issue":"1","key":"6639_CR54","doi-asserted-by":"publisher","first-page":"87","DOI":"10.55133\/eji.310110","volume":"31","author":"M El Said","year":"2024","unstructured":"El Said M, Alshanberi AM, Abouelmagd F, Shaikhomer M, Hassan FE (2024) Insight on the hepatitis B virus and host immune mechanisms in the context of occult hepatitis. Egypt J Immunol 31(1):87\u2013105. https:\/\/doi.org\/10.55133\/eji.310110","journal-title":"Egypt J Immunol"},{"key":"6639_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4137\/jcd.s39824","volume":"9","author":"L Cao","year":"2016","unstructured":"Cao L, Quan XB, Zeng WJ, Yang XO, Wang MJ (2016) Mechanism of Hepatocyte Apoptosis. J Cell Death 9:19\u201329. https:\/\/doi.org\/10.4137\/jcd.s39824","journal-title":"J Cell Death"},{"issue":"3","key":"6639_CR56","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.cyto.2009.06.005","volume":"47","author":"CM Martin","year":"2009","unstructured":"Martin CM, Welge JA, Shire NJ, Shata MT, Sherman KE, Blackard JT (2009) Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals. Cytokine 47(3):194\u2013198. https:\/\/doi.org\/10.1016\/j.cyto.2009.06.005","journal-title":"Cytokine"},{"issue":"4","key":"6639_CR57","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.arcmed.2010.07.001","volume":"41","author":"G Hassanshahi","year":"2010","unstructured":"Hassanshahi G, Arababadi MK, Khoramdelazad H, Yaghini N, Zarandi ER (2010) Assessment of CXCL12 (SDF-1\u03b1) polymorphisms and its serum level in posttransfusion occult HBV-infected patients in Southeastern Iran. Arch med res 41(4):338\u2013342. https:\/\/doi.org\/10.1016\/j.arcmed.2010.07.001","journal-title":"Arch med res"},{"issue":"8","key":"6639_CR58","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1111\/j.1537-2995.2009.02188.x","volume":"49","author":"CM Bremer","year":"2009","unstructured":"Bremer CM, Saniewski M, Wend UC, Torres P, Lelie N, Gerlich WH, Glebe D (2009) Transient occult hepatitis B virus infection in a blood donor with high viremia. Transfusion 49(8):1621\u20131629. https:\/\/doi.org\/10.1111\/j.1537-2995.2009.02188.x","journal-title":"Transfusion"},{"issue":"1","key":"6639_CR59","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1440-1746.2009.05950.x","volume":"25","author":"MK Arababadi","year":"2010","unstructured":"Arababadi MK, Pourfathollah AA, Jafarzadeh A, Hassanshahi G, Rezvani ME (2010) Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in south-eastern Iranian patients. J Gastroenterol Hepatol 25(1):90\u201393. https:\/\/doi.org\/10.1111\/j.1440-1746.2009.05950.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"6639_CR60","doi-asserted-by":"publisher","first-page":"110107","DOI":"10.4254\/wjh.v17.i10.110107","volume":"17","author":"S Marrapu","year":"2025","unstructured":"Marrapu S, Soni JR, Kamal K, Kumar R (2025) Hepatitis B functional cure: Current and future perspective. World J Hepatol 17(10):110107. https:\/\/doi.org\/10.4254\/wjh.v17.i10.110107","journal-title":"World J Hepatol"},{"key":"6639_CR61","doi-asserted-by":"publisher","first-page":"1611976","DOI":"10.3389\/fimmu.2025.1611976","volume":"16","author":"Y Shu","year":"2025","unstructured":"Shu Y, Li S, Du Y, Zheng X (2025) Anti-HBV treatment partially restores the dysfunction of innate immune cells and unconventional T cells during chronic HBV infection. Front Immunol 16:1611976. https:\/\/doi.org\/10.3389\/fimmu.2025.1611976","journal-title":"Front Immunol"},{"key":"6639_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-025-02805-2","volume":"145","author":"L Zhou","year":"2025","unstructured":"Zhou L, Yan Y, Ji H, Sun H, Lu Z, Chang L, Wang L (2025) Exploratory analysis of HLA SNPs associated with occult HBV infection: a multicenter case\u2013control study in Chinese blood donors. Hum Genet 145:1. https:\/\/doi.org\/10.1007\/s00439-025-02805-2","journal-title":"Hum Genet"},{"issue":"1","key":"6639_CR63","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13104-025-07337-6","volume":"18","author":"HM Kafeero","year":"2025","unstructured":"Kafeero HM, Ocama P, Ndagire D, Walusansa A, Namusoke M, Kudamba A, Muwanda F, Sendagire H (2025) The status of occult HBV infection in a high endemic region: risk of community HBV transmission and reactivation. BMC Res Notes 18(1):255. https:\/\/doi.org\/10.1186\/s13104-025-07337-6","journal-title":"BMC Res Notes"},{"issue":"13","key":"6639_CR64","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.3748\/wjg.v22.i13.3531","volume":"22","author":"HL Zhu","year":"2016","unstructured":"Zhu HL, Li X, Li J, Zhang ZH (2016) Genetic variation of occult hepatitis B virus infection. World J Gastroenterol 22(13):3531\u20133546. https:\/\/doi.org\/10.3748\/wjg.v22.i13.3531","journal-title":"World J Gastroenterol"},{"issue":"12","key":"6639_CR65","doi-asserted-by":"publisher","first-page":"860","DOI":"10.4254\/wjh.v6.i12.860","volume":"6","author":"M-S Kwak","year":"2014","unstructured":"Kwak M-S, Kim YJ (2014) Occult hepatitis B virus infection. World J Hepatol 6(12):860\u2013869. https:\/\/doi.org\/10.4254\/wjh.v6.i12.860","journal-title":"World J Hepatol"},{"key":"6639_CR66","unstructured":"Londono JR (2017) Genetic characterizations and epigenetic interference to better understand and fight occult Hepatitis B virus infection. [Thesis fully internal (DIV), University of Groningen]"},{"issue":"5","key":"6639_CR67","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1086\/655398","volume":"202","author":"P Kaur","year":"2010","unstructured":"Kaur P, Paliwal A, Durantel D, Hainaut P, Scoazec J-Y, Zoulim F, Chemin I, Herceg Z (2010) DNA methylation of hepatitis B virus (HBV) genome associated with the development of hepatocellular carcinoma and occult HBV infection. J Infect Dis 202(5):700\u2013704. https:\/\/doi.org\/10.1086\/655398","journal-title":"J Infect Dis"},{"issue":"12","key":"6639_CR68","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.7150\/thno.8715","volume":"4","author":"KL Xie","year":"2014","unstructured":"Xie KL, Zhang YG, Liu J, Zeng Y, Wu H (2014) MicroRNAs associated with HBV infection and HBV-related HCC. Theranostics 4(12):1176\u20131192. https:\/\/doi.org\/10.7150\/thno.8715","journal-title":"Theranostics"},{"issue":"1","key":"6639_CR69","doi-asserted-by":"publisher","first-page":"2421231","DOI":"10.1080\/21505594.2024.2421231","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Cao W, Wang S, Zhang L, Li X, Zhang Z, Xie Y, Li M (2024) Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma. Virulence 15(1):2421231. https:\/\/doi.org\/10.1080\/21505594.2024.2421231","journal-title":"Virulence"},{"issue":"12","key":"6639_CR70","doi-asserted-by":"publisher","first-page":"e0241524","DOI":"10.1128\/mbio.02415-24","volume":"15","author":"K Hu","year":"2024","unstructured":"Hu K, Zai W, Xu M, Wang H, Song X, Huang C, Liu J, Chen J, Deng Q, Yuan Z, Chen J (2024) Augmented epigenetic repression of hepatitis B virus covalently closed circular DNA by interferon-\u03b1 and small-interfering RNA synergy. mBio 15(12):e0241524. https:\/\/doi.org\/10.1128\/mbio.02415-24","journal-title":"mBio"},{"key":"6639_CR71","doi-asserted-by":"publisher","first-page":"1537929","DOI":"10.3389\/fcimb.2025.1537929","volume":"15","author":"J Kim","year":"2025","unstructured":"Kim J, Ha J, Song C, Sajjad MA, Kalsoom F, Kwon H, Park J, Park S, Kim K (2025) Sirtuin 2 inhibitor AGK2 exerts antiviral effects by inducing epigenetic suppression of hepatitis B virus covalently closed circular DNA through recruitment of repressive histone lysine methyltransferases and reduction of cccDNA. Front Cell Infect Microbiol 15:1537929. https:\/\/doi.org\/10.3389\/fcimb.2025.1537929","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"6639_CR72","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1080\/08820139.2025.2532630","volume":"54","author":"JK Sevak","year":"2025","unstructured":"Sevak JK, Islam M, Verma G, Saxena A, E PB, Parveen S, Jindal A, Sharma MK, Ramakrishna G, Kazim SN, Sarin SK, Trehanpati N (2025) Differential Methylation Patterns Predict HBsAg Seroconversion in Hepatitis B Virus Reactivation Patients. Immunol Invest 54(7):1220\u20131240. https:\/\/doi.org\/10.1080\/08820139.2025.2532630","journal-title":"Immunol Invest"},{"key":"6639_CR73","doi-asserted-by":"publisher","first-page":"23725","DOI":"10.1038\/s41598-025-09655-y","volume":"15","author":"L Gailhouste","year":"2025","unstructured":"Gailhouste L, Furutani Y, Qin X-Y, Higuchi S, Toguchi M, Yanaka K, Watashi K, Wakita T, Kojima S (2025) miRNA-29b-1-5p mediates an antiviral activity by targeting the HBV entry receptor in human hepatocytes. Sci Rep 15:23725. https:\/\/doi.org\/10.1038\/s41598-025-09655-y","journal-title":"Sci Rep"},{"issue":"1","key":"6639_CR74","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12935-025-03849-0","volume":"25","author":"YH Lin","year":"2025","unstructured":"Lin YH, Lai MW, Yeh CT, Lin WR (2025) Perspectives on NcRNAs in HBV\/cccDNA-driven HCC progression. Cancer Cell Int 25(1):224. https:\/\/doi.org\/10.1186\/s12935-025-03849-0","journal-title":"Cancer Cell Int"},{"issue":"1","key":"6639_CR75","doi-asserted-by":"publisher","first-page":"2475847","DOI":"10.1080\/22221751.2025.2475847","volume":"14","author":"B Jiang","year":"2025","unstructured":"Jiang B, Guan G, Zhao K, Gu Z, Wang L, Gu W, Li M, Xia Y, Chen X, Guo Y, Zhang J, Cao Z, Yuen MF, Lu F (2025) Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFN\u03b1 treated patients of chronic hepatitis B. Emerg Microbes Infect 14(1):2475847. https:\/\/doi.org\/10.1080\/22221751.2025.2475847","journal-title":"Emerg Microbes Infect"},{"issue":"21","key":"6639_CR76","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1111\/febs.14094","volume":"284","author":"KO Hensel","year":"2017","unstructured":"Hensel KO, Rendon JC, Navas MC, Rots MG, Postberg J (2017) Virus\u2013host interplay in hepatitis B virus infection and epigenetic treatment strategies. FEBS J 284(21):3550\u20133572. https:\/\/doi.org\/10.1111\/febs.14094","journal-title":"FEBS J"},{"key":"6639_CR77","doi-asserted-by":"publisher","first-page":"1349867","DOI":"10.3389\/fimmu.2024.1349867","volume":"15","author":"Z Wang","year":"2024","unstructured":"Wang Z, Liu N, Yang Y, Tu Z (2024) The novel mechanism facilitating chronic hepatitis B infection: immunometabolism and epigenetic modification reprogramming. Front Immunol 15:1349867. https:\/\/doi.org\/10.3389\/fimmu.2024.1349867","journal-title":"Front Immunol"},{"issue":"7","key":"6639_CR78","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/v17070974","volume":"17","author":"T Yan","year":"2025","unstructured":"Yan T, Zhang Y, Zhou H, Jiang N, Wang X, Yan W, Yin J (2025) Surface Gene Mutations of Hepatitis B Virus and Related Pathogenic Mechanisms: A Narrative Review. Viruses 17(7):974. https:\/\/doi.org\/10.3390\/v17070974","journal-title":"Viruses"},{"issue":"9","key":"6639_CR79","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s10096-015-2422-x","volume":"34","author":"R Pond\u00e9","year":"2015","unstructured":"Pond\u00e9 R (2015) Molecular mechanisms underlying HBsAg negativity in occult HBV infection. Eur J Clin Microbiol Infect Dis 34(9):1709\u20131731. https:\/\/doi.org\/10.1007\/s10096-015-2422-x","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"6639_CR80","doi-asserted-by":"publisher","first-page":"8194","DOI":"10.1038\/s41598-022-12288-0","volume":"12","author":"M Wang","year":"2022","unstructured":"Wang M, Xu R, Huang J, Liao Q, Tang X, Shan Z, Zhong H, Rong X, Fu Y (2022) Molecular characteristics of the full-length genome of occult hepatitis B virus from blood donors in China. Sci Rep 12:8194. https:\/\/doi.org\/10.1038\/s41598-022-12288-0","journal-title":"Sci Rep"},{"issue":"12","key":"6639_CR81","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.3748\/wjg.v17.i12.1538","volume":"17","author":"ML Guti\u00e9rrez-Garc\u00eda","year":"2011","unstructured":"Guti\u00e9rrez-Garc\u00eda ML, Fernandez-Rodriguez CM, Lledo-Navarro JL, Buhigas-Garcia I (2011) Prevalence of occult hepatitis B virus infection. World J Gastroenterol 17(12):1538\u20131542. https:\/\/doi.org\/10.3748\/wjg.v17.i12.1538","journal-title":"World J Gastroenterol"},{"issue":"10","key":"6639_CR82","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/infdis\/jiad140","volume":"228","author":"X Tang","year":"2023","unstructured":"Tang X, Yang L, Zhang P, Wang C, Luo S, Liu B, Fu Y, Candotti D, Allain J-P, Zhang L (2023) Occult hepatitis B virus infection and liver fibrosis in chinese patients. J Infect Dis 228(10):1375\u20131384. https:\/\/doi.org\/10.1093\/infdis\/jiad140","journal-title":"J Infect Dis"},{"issue":"20","key":"6639_CR83","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.3748\/wjg.v20.i20.5951","volume":"20","author":"T Pollicino","year":"2014","unstructured":"Pollicino T, Saitta C (2014) Occult hepatitis B virus and hepatocellular carcinoma. World J Gastroenterol 20(20):5951\u20135961. https:\/\/doi.org\/10.3748\/wjg.v20.i20.5951","journal-title":"World J Gastroenterol"},{"issue":"7","key":"6639_CR84","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3390\/v14071504","volume":"14","author":"C Saitta","year":"2022","unstructured":"Saitta C, Pollicino T, Raimondo G (2022) Occult Hepatitis B Virus Infection: An Update. Viruses 14(7):1504. https:\/\/doi.org\/10.3390\/v14071504","journal-title":"Viruses"},{"key":"6639_CR85","doi-asserted-by":"publisher","first-page":"972687","DOI":"10.3389\/fmicb.2022.972687","volume":"13","author":"R Salpini","year":"2022","unstructured":"Salpini R, D\u2019Anna S, Benedetti L, Piermatteo L, Gill U, Svicher V, Kennedy PTF (2022) Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure. Front Microbiol 13:972687. https:\/\/doi.org\/10.3389\/fmicb.2022.972687","journal-title":"Front Microbiol"},{"issue":"1","key":"6639_CR86","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13046-019-1273-1","volume":"38","author":"X-P Chen","year":"2019","unstructured":"Chen X-P, Long X, Jia W-l, Wu H-J, Zhao J, Liang H-F, Laurence A, Zhu J, Dong D, Chen Y, Lin L, Xia Y-D, Li W-Y, Li G-B, Zhao Z-K, Wu K, Hou Y, Yu J-J, Xiao W, Wang G-P, Zhu P-C, Chen W, Bai M-Z, Jian Y-X, Kristiansen K, Chen Q (2019) Viral integration drives multifocal HCC during the occult HBV infection. J Exp Clin Cancer Res 38(1):261. https:\/\/doi.org\/10.1186\/s13046-019-1273-1","journal-title":"J Exp Clin Cancer Res"},{"key":"6639_CR87","doi-asserted-by":"publisher","first-page":"46","DOI":"10.21037\/dmr-21-50","volume":"4","author":"C Weng","year":"2021","unstructured":"Weng C, Kumar R, Sultana R, Chow WC (2021) Occult hepatitis B virus infection and the risk of hepatocellular carcinoma: a systematic review and meta-analysis. dig med res 4:46. https:\/\/doi.org\/10.21037\/dmr-21-50","journal-title":"dig med res"},{"issue":"6","key":"6639_CR88","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jmii.2019.04.009","volume":"53","author":"X-x Chen","year":"2020","unstructured":"Chen X-x, Xiang K-h, Zhang H-p, Kong X-s, Huang C-y, Liu Y-m, Lou J-l, Gao Z-h, Yan H-p (2020) Occult HBV infection in patients with autoimmune hepatitis: a virological and clinical study. J Microbiol Immunol Infect 53(6):946\u2013954. https:\/\/doi.org\/10.1016\/j.jmii.2019.04.009","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"6639_CR89","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00296-015-3395-x","volume":"36","author":"M Kato","year":"2016","unstructured":"Kato M, Atsumi T (2016) Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention. Rheumatol Int 36(5):635\u2013641. https:\/\/doi.org\/10.1007\/s00296-015-3395-x","journal-title":"Rheumatol Int"},{"issue":"3","key":"6639_CR90","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1478-3231.2008.01851.x","volume":"29","author":"SP Georgiadou","year":"2009","unstructured":"Georgiadou SP, Zachou K, Liaskos C, Gabeta S, Rigopoulou EI, Dalekos GN (2009) Occult hepatitis B virus infection in patients with autoimmune liver diseases. Liver Int 29(3):434\u2013442. https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01851.x","journal-title":"Liver Int"},{"issue":"4","key":"6639_CR91","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.transproceed.2009.03.001","volume":"41","author":"P Stratta","year":"2009","unstructured":"Stratta P, Bruschetta E, Minisini R, Barbe M, Cornella C, Tognarelli G, Cena T, Magnani C, Fenoglio R, Toffolo K (2009) Prevalence and clinical relevance of occult hepatitis B virus infection in patients on the waiting list for kidney transplantation. Transpl Proc 41(4):1132\u20131137. https:\/\/doi.org\/10.1016\/j.transproceed.2009.03.001","journal-title":"Transpl Proc"},{"issue":"4","key":"6639_CR92","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/diagnostics15040486","volume":"15","author":"AS Alshrari","year":"2025","unstructured":"Alshrari AS, Hudu SA, Shinkafi SH, Tahir A, Raji HY, Jimoh AO (2025) Prevalence and Transfusion Risks of Occult Hepatitis B Infection Among HBcAb-Positive Blood Donors in a High-Endemic Region. Diagnostics 15(4):486. https:\/\/doi.org\/10.3390\/diagnostics15040486","journal-title":"Diagnostics"},{"key":"6639_CR93","doi-asserted-by":"publisher","unstructured":"Fu MX, Elsharkawy A, Healy B, Jackson C, Bradshaw D, Watkins E, Ushiro-Lumb I, Griffiths J, Neuberger J, Maguire K, Desai M, McDougall N, Priddee N, Barclay ST, Blackmore S, Simmonds P, Irving WL, Harvala H (2025) Occult hepatitis B virus infection: risk for a blood supply, but how about individuals\u2019 health? eClinicalMedicine. 81:103095. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103095","DOI":"10.1016\/j.eclinm.2025.103095"},{"issue":"1","key":"6639_CR94","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jhep.2006.10.007","volume":"46","author":"G Raimondo","year":"2007","unstructured":"Raimondo G, Pollicino T, Cacciola I, Squadrito G (2007) Occult hepatitis B virus infection. J Hepatol 46(1):160\u2013170. https:\/\/doi.org\/10.1016\/j.jhep.2006.10.007","journal-title":"J Hepatol"},{"key":"6639_CR95","first-page":"312","volume":"132","author":"M Asim","year":"2010","unstructured":"Asim M, Ali R, Khan LA, Husain S, Singla R, Kar P (2010) Significance of anti-HBc screening of blood donors & its association with occult hepatitis B virus infection: Implications for blood transfusion. Indian J Med Res 132:312\u2013317 PMID: 20847378","journal-title":"Indian J Med Res"},{"issue":"3","key":"6639_CR96","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4254\/wjh.v7.i3.600","volume":"7","author":"DH Seo","year":"2015","unstructured":"Seo DH, Whang DH, Song EY, Han KS (2015) Occult hepatitis B virus infection and blood transfusion. World J Hepatol 7(3):600\u2013606. https:\/\/doi.org\/10.4254\/wjh.v7.i3.600","journal-title":"World J Hepatol"},{"issue":"4","key":"6639_CR97","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jhep.2020.05.042","volume":"73","author":"LY Mak","year":"2020","unstructured":"Mak LY, Wong DK, Pollicino T, Raimondo G, Hollinger FB, Yuen MF (2020) Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance. J Hepatol 73(4):952\u2013964. https:\/\/doi.org\/10.1016\/j.jhep.2020.05.042","journal-title":"J Hepatol"},{"issue":"1","key":"6639_CR98","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41598-020-57603-9","volume":"10","author":"K Murai","year":"2020","unstructured":"Murai K, Hikita H, Kai Y, Kondo Y, Fukuoka M, Fukutomi K, Doi A, Yamai T, Nakabori T, Fukuda R, Takahashi T, Miyakawa K, Suemizu H, Ryo A, Yamada R, Kodama T, Sakamori R, Tatsumi T, Takehara T (2020) Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway. Sci Rep 10(1):941. https:\/\/doi.org\/10.1038\/s41598-020-57603-9","journal-title":"Sci Rep"},{"key":"6639_CR99","doi-asserted-by":"publisher","unstructured":"Yu G, Chi X, Wu R, Wang X, Gao X, Kong F, Feng X, Gao Y, Huang X, Jin J, Qi Y, Tu Z, Sun B, Zhong J, Pan Y, Niu J (2015) Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese Population. PLOS ONE 30;10(9):e0139015. https:\/\/doi.org\/10.1371\/journal.pone.0139015","DOI":"10.1371\/journal.pone.0139015"},{"issue":"9","key":"6639_CR100","doi-asserted-by":"publisher","first-page":"e45146","DOI":"10.1371\/journal.pone.0045146","volume":"7","author":"W Zhu","year":"2012","unstructured":"Zhu W, Wu C, Deng W, Pei R, Wang Y, Cao L, Qin B, Lu M, Chen X (2012) Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo. PLoS ONE 7(9):e45146. https:\/\/doi.org\/10.1371\/journal.pone.0045146","journal-title":"PLoS ONE"},{"issue":"4","key":"6639_CR101","doi-asserted-by":"publisher","first-page":"e00014","DOI":"10.1128\/mmbr.00014-24","volume":"88","author":"Y-C Chuang","year":"2024","unstructured":"Chuang Y-C, Ou J-HJ (2024) Hepatitis B virus entry, assembly, and egress. Microbiol Mol Biol Rev 88(4):e00014\u201300024. https:\/\/doi.org\/10.1128\/mmbr.00014-24","journal-title":"Microbiol Mol Biol Rev"},{"issue":"12","key":"6639_CR102","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3748\/wjg.v17.i12.1553","volume":"17","author":"S Ocana","year":"2011","unstructured":"Ocana S, Casas ML, Buhigas I, Lledo JL (2011) Diagnostic strategy for occult hepatitis B virus infection. World J Gastroenterol 17(12):1553\u20131557. https:\/\/doi.org\/10.3748\/wjg.v17.i12.1553","journal-title":"World J Gastroenterol"},{"issue":"5","key":"6639_CR103","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/jvh.13817","volume":"30","author":"F Sun","year":"2023","unstructured":"Sun F, Xia W, Ouyang Y (2023) Research progress on detection methods for hepatitis B virus covalently closed circular DNA. J J Viral Hepat 30(5):366\u2013373. https:\/\/doi.org\/10.1111\/jvh.13817","journal-title":"J J Viral Hepat"},{"issue":"1","key":"6639_CR104","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/hep.28280","volume":"63","author":"AS Lok","year":"2016","unstructured":"Lok AS, McMahon BJ, Brown RS Jr., Wong JB, Ahmed AT, Farah W, Almasri J, Alahdab F, Benkhadra K, Mouchli MA, Singh S, Mohamed EA, Abu Dabrh AM, Prokop LJ, Wang Z, Murad MH, Mohammed K (2016) Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis. Hepatology 63(1):284\u2013306. https:\/\/doi.org\/10.1002\/hep.28280","journal-title":"Hepatology"},{"issue":"2","key":"6639_CR105","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s00103-022-03486-2","volume":"65","author":"S Nkongolo","year":"2022","unstructured":"Nkongolo S, Hollnberger J, Urban S (2022) Bulevirtide as the first specific agent against hepatitis D virus infections-mechanism and clinical effect. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 65(2):254\u2013263. https:\/\/doi.org\/10.1007\/s00103-022-03486-2","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"4","key":"6639_CR106","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jhep.2024.05.001","volume":"81","author":"H Wedemeyer","year":"2024","unstructured":"Wedemeyer H, Aleman S, Brunetto M, Blank A, Andreone P, Bogomolov P, Chulanov V, Mamonova N, Geyvandova N, Morozov V, Sagalova O, Stepanova T, Berger A, Ciesek S, Manuilov D, Mercier RC, Da BL, Chee GM, Li M, Flaherty JF, Lau AH, Osinusi A, Schulze Zur Wiesch J, Cornberg M, Zeuzem S, Lampertico P (2024) Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial. J Hepatol 81(4):621\u2013629. https:\/\/doi.org\/10.1016\/j.jhep.2024.05.001","journal-title":"J Hepatol"},{"issue":"1","key":"6639_CR107","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/ijms25010334","volume":"25","author":"UI Bartosh","year":"2024","unstructured":"Bartosh UI, Dome AS, Zhukova NV, Karitskaya PE, Stepanov GA (2024) CRISPR\/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections. Int J Mol Sci 25(1):334. https:\/\/doi.org\/10.3390\/ijms25010334","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6639_CR108","doi-asserted-by":"publisher","first-page":"101533","DOI":"10.1016\/j.aohep.2024.101533","volume":"30","author":"PG Naully","year":"2025","unstructured":"Naully PG, Tan MI, Agustiningsih A, Sukowati C, Giri-Rachman EA (2025) cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B. Ann Hepatol 30(1):101533. https:\/\/doi.org\/10.1016\/j.aohep.2024.101533","journal-title":"Ann Hepatol"},{"key":"6639_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2161-038X.1000102","volume":"1","author":"Z Shi","year":"2012","unstructured":"Shi Z, Li X, Yang Y, Ma L, Schreiber A (2012) Obstetrical Management of Fulminant Viral Hepatitis in Late Pregnancy. Reproductive Sys Sex Disord 1:1. https:\/\/doi.org\/10.4172\/2161-038X.1000102","journal-title":"Reproductive Sys Sex Disord"},{"issue":"2","key":"6639_CR110","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","volume":"83","author":"M Cornberg","year":"2025","unstructured":"European Association for the Study of the L, Cornberg M, Sandmann L, Jaroszewicz J, Kennedy P, Lampertico P, Lemoine M, Lens S, Testoni B, Lai-Hung Wong G, Russo FP (2025) EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 83(2):502\u2013583. https:\/\/doi.org\/10.1016\/j.jhep.2025.03.018","journal-title":"J Hepatol"},{"issue":"12","key":"6639_CR111","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3748\/wjg.v17.i12.1563","volume":"17","author":"JL Lled\u00f3","year":"2011","unstructured":"Lled\u00f3 JL, Fern\u00e1ndez C, Guti\u00e9rrez ML, Oca\u00f1a S (2011) Management of occult hepatitis B virus infection: an update for the clinician. World J Gastroenterol WJG 17(12):1563\u20131568. https:\/\/doi.org\/10.3748\/wjg.v17.i12.1563","journal-title":"World J Gastroenterol WJG"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-026-06639-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-026-06639-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-026-06639-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:52:45Z","timestamp":1780764765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-026-06639-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":111,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["6639"],"URL":"https:\/\/doi.org\/10.1007\/s00705-026-06639-9","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest that pertain to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}